GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cordlife Group Ltd (SGX:P8A) » Definitions » Price-to-Owner-Earnings

Cordlife Group (SGX:P8A) Price-to-Owner-Earnings : 3.50 (As of Jun. 06, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Cordlife Group Price-to-Owner-Earnings?

As of today (2024-06-06), Cordlife Group's share price is S$0.14. Cordlife Group's Owner Earnings per Share (TTM) ended in Dec. 2023 was S$0.04. It's Price-to-Owner-Earnings for today is 3.50.


The historical rank and industry rank for Cordlife Group's Price-to-Owner-Earnings or its related term are showing as below:

SGX:P8A' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 3.43   Med: 12.91   Max: 46.21
Current: 4.14

During the past 12 years, the highest Price-to-Owner-Earnings of Cordlife Group was 46.21. The lowest was 3.43. And the median was 12.91.


SGX:P8A's Price-to-Owner-Earnings is ranked better than
89.55% of 67 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.4 vs SGX:P8A: 4.14

As of today (2024-06-06), Cordlife Group's share price is S$0.14. Cordlife Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was S$0.01. Therefore, Cordlife Group's PE Ratio for today is 10.00.

As of today (2024-06-06), Cordlife Group's share price is S$0.14. Cordlife Group's EPS without NRI for the trailing twelve months (TTM) ended in was S$0.01. Therefore, Cordlife Group's PE Ratio without NRI for today is 10.00.

During the past 12 years, Cordlife Group's highest PE Ratio without NRI was 134.00. The lowest was 8.57. And the median was 23.19.


Cordlife Group Price-to-Owner-Earnings Historical Data

The historical data trend for Cordlife Group's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cordlife Group Price-to-Owner-Earnings Chart

Cordlife Group Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.00 8.40 15.38 11.43 9.00

Cordlife Group Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.38 - 11.43 - 9.00

Competitive Comparison of Cordlife Group's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Cordlife Group's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cordlife Group's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cordlife Group's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Cordlife Group's Price-to-Owner-Earnings falls into.



Cordlife Group Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Cordlife Group's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.14/0.04
=3.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cordlife Group  (SGX:P8A) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Cordlife Group Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Cordlife Group's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Cordlife Group (SGX:P8A) Business Description

Traded in Other Exchanges
Address
1 Yishun Industrial Street 1, Number 06-01/09, A'Posh Bizhub, Singapore, SGP, 768160
Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Cordlife has processing and storage facilities in six key markets across Asia, namely Singapore, Hong Kong, Malaysia, India, Indonesia, and the Philippines. The company has two segments - The Banking segment, comprises cord blood, cord lining, and cord tissue services. The Diagnostics segment comprises Metascreen, which is a non-invasive metabolic screening test specially designed for newborn babies, non-invasive prenatal testing service and Eyescreen, a paediatric eye-screening service.

Cordlife Group (SGX:P8A) Headlines

No Headlines